Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/103066
Title: | Subclinical depressive symptoms and continued cannabis use: predictors of negative outcomes in first episode psychosis |
Author: | González Ortega, Itxaso Alberich, Susana Echeburúa, Enrique Aizpuru, Felipe Millán, Eduardo Vieta i Pascual, Eduard, 1963- Matute, Carlos González-Pinto, Ana |
Keywords: | Depressió psíquica Cànnabis Psicosi Psicopatologia Mental depression Cannabis Psychoses Pathological psychology |
Issue Date: | 15-Apr-2015 |
Publisher: | Public Library of Science (PLoS) |
Abstract: | BACKGROUND: Although depressive symptoms in first episode psychosis have been associated with cannabis abuse, their influence on the long-term functional course of FEP patients who abuse cannabis is unknown. The aims of the study were to examine the influence of subclinical depressive symptoms on the long-term outcome in first episode-psychosis patients who were cannabis users and to assess the influence of these subclinical depressive symptoms on the ability to quit cannabis use. METHODS: 64 FEP patients who were cannabis users at baseline were followed-up for 5 years. Two groups were defined: (a) patients with subclinical depressive symptoms at least once during follow-up (DPG), and (b) patients without subclinical depressive symptoms during follow-up (NDPG). Psychotic symptoms were measured using the Positive and Negative Syndrome Scale (PANSS), depressive symptoms using the Hamilton Depression Rating Scale (HDRS)-17, and psychosocial functioning was assessed using the Global Assessment of Functioning (GAF). A linear mixed-effects model was used to analyze the combined influence of cannabis use and subclinical depressive symptomatology on the clinical outcome. RESULTS: Subclinical depressive symptoms were associated with continued abuse of cannabis during follow-up (β= 4.45; 95% confidence interval [CI]: 1.78 to 11.17; P = .001) and with worse functioning (β = -5.50; 95% CI: -9.02 to -0.33; P = .009). CONCLUSIONS: Subclinical depressive symptoms and continued cannabis abuse during follow-up could be predictors of negative outcomes in FEP patients. |
Note: | Reproducció del document publicat a: http://dx.doi.org/10.1371/journal.pone.0123707 |
It is part of: | PLoS One, 2015, vol. 10, num. 4, p. e0123707 |
URI: | http://hdl.handle.net/2445/103066 |
Related resource: | http://dx.doi.org/10.1371/journal.pone.0123707 |
ISSN: | 1932-6203 |
Appears in Collections: | Articles publicats en revistes (Medicina) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
651824.pdf | 185.22 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License